Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Neuroprotection Rodent models show BPC-157 exerting neuroprotective effects via anti-apoptotic and anti-inflammatory signaling in the central nervous system (CNS)
Cell Biol Toxicol
Topical copper peptides offer an alternative with different risk profiles
UBX0101 (MDM2 inhibitor, Unity Biotechnology) targeted p53-MDM2 interaction in senescent cellsPhase 2 for knee OA failed in 2020
Products are labeled for Research Use Only (RUO) in accordance with applicable FDA guidance and 21 CFR 809.10(c)(2) and are not drugs, dietary supplements, or medical products